TrialOncotarget2017

A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer.

Antonin Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.